Myasthenic crisis is a life-threatening complication of myasthenia gravis in which muscle weakness becomes severe enough to cause respiratory failure. It requires emergency admission to an intensive care unit and often mechanical ventilation. About 15 to 20 percent of people with myasthenia gravis will experience at least one crisis during their lifetime, and recognizing the warning signs early can make the difference between a manageable hospital stay and a dangerous emergency.
How a Crisis Differs From Typical Myasthenia Gravis
Myasthenia gravis normally causes fluctuating weakness in specific muscle groups, often the eyes, face, and limbs. In a crisis, that weakness escalates to involve the muscles you use to breathe. The diaphragm, the intercostal muscles between your ribs, and the accessory muscles in your neck all play a role in pulling air into your lungs. In myasthenia gravis, the intercostal and accessory muscles tend to weaken first, followed by the diaphragm.
Upper airway muscles can also fail. When the muscles controlling the tongue and throat weaken, the airway can collapse or become obstructed, forcing already fatigued breathing muscles to work even harder against a partially closed passage. This combination of respiratory muscle weakness and upper airway compromise is what makes myasthenic crisis a medical emergency rather than just a bad flare.
Warning Signs Before a Crisis
Myasthenic crisis rarely strikes without warning. In the days or weeks leading up to it, most people notice a worsening pattern of bulbar symptoms, the term for weakness in the muscles of the face, mouth, and throat. These include increasingly nasal-sounding speech, difficulty swallowing that may lead to noticeable weight loss, and a voice that fades or becomes hoarse during conversation. One case study documented a patient losing about 5 kg (11 pounds) over several months as swallowing became progressively harder.
Breathing-specific red flags include shortness of breath when lying flat (orthopnea), rapid shallow breathing, and a feeling that you simply cannot take a full breath. In a clinical setting, doctors track two key measurements to gauge how close someone is to crisis: forced vital capacity (FVC), which measures how much air you can forcefully exhale, and negative inspiratory force (NIF), which measures how strongly you can inhale. An FVC dropping below 15 mL per kilogram of body weight or a NIF weaker than negative 20 cm of water pressure typically signals the need for ventilatory support.
Common Triggers
Infection is the single most common trigger for myasthenic crisis. Respiratory infections are particularly dangerous because they stress the very muscles that are already vulnerable. Beyond infections, a wide range of factors can push someone from stable myasthenia gravis into crisis:
- Surgery and anesthesia, especially procedures involving the chest or airway
- Certain medications, including several common antibiotic classes
- Reduction or sudden withdrawal of myasthenia gravis medications
- Physical and emotional stress, pain, and sleep deprivation
- Temperature extremes, both overheating and excessive cold
- Pregnancy
The medication issue deserves special attention. The FDA has placed black box warnings on two categories of antibiotics for people with myasthenia gravis: fluoroquinolones (ciprofloxacin, moxifloxacin, levofloxacin) and telithromycin. Macrolide antibiotics like azithromycin and aminoglycosides like gentamicin can also worsen symptoms significantly. If you have myasthenia gravis, keeping a list of these drug classes and sharing it with every prescribing doctor or pharmacist is one of the most practical steps you can take to avoid a crisis.
What Happens in the ICU
Once someone is admitted for myasthenic crisis, the first priority is ensuring they can breathe. Some patients can be supported with BiPAP, a non-invasive mask that helps push air into the lungs. Others need intubation, where a tube is placed into the airway and connected to a mechanical ventilator. The decision depends on how weak the breathing muscles have become and whether the person can still clear secretions from their throat effectively.
Alongside breathing support, doctors start one of two rapid-acting treatments designed to reduce the immune system’s attack on the nerve-muscle connection. Plasma exchange (sometimes called plasmapheresis) physically filters harmful antibodies out of the blood over five to six sessions performed on alternate days. Intravenous immunoglobulin (IVIg) floods the body with donated antibodies that help neutralize the immune attack, given daily over three to five days. Clinical trials comparing the two have found no significant difference in effectiveness. The choice often comes down to what’s available at the hospital and whether the patient has other health conditions that make one option safer than the other.
These rapid therapies work as a bridge. They bring the crisis under control while longer-term immunosuppressive medications, which take weeks or months to reach full effect, are adjusted or initiated.
Recovery and Time on a Ventilator
Recovery from myasthenic crisis is not quick. The average hospital stay is about 12 days, but patients who require mechanical ventilation face a longer road. Data from a recent intensive care study found the median duration on a ventilator was 20 days, and most patients experienced intermediate or prolonged weaning rather than a rapid return to independent breathing.
Weaning from the ventilator happens in stages. Doctors wait until the underlying trigger (usually an infection) has resolved and the immune-targeted treatment has had time to work. They also look for physical milestones: the ability to lift your head and elbows off the bed, cough effectively, and manage airway secretions on your own. Once those criteria are met, breathing trials begin, starting at 30 to 60 minutes and gradually extending to several hours. The median time from the first breathing trial to successful weaning is about 7 days, though some patients need considerably longer.
Long-Term Outlook
Myasthenic crisis was once frequently fatal, but modern ICU care has dramatically improved survival. Mortality has dropped from around 40 percent in earlier decades to well under 10 percent in specialized centers today. The risk of death also tends to decrease the longer someone has had myasthenia gravis, likely because long-term patients and their doctors become better at recognizing early warning signs and managing triggers.
Having one crisis does increase your risk of having another, which is why adjusting long-term immunosuppressive therapy after a crisis is a key part of follow-up care. Many people who survive a crisis return to their previous level of function, though recovery can take weeks to months depending on how severe the episode was and how long ventilatory support was needed.